AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $873.34 million. The enterprise value is $218.40 million.
| Market Cap | 873.34M |
| Enterprise Value | 218.40M |
Important Dates
The next confirmed earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 294.05 million shares outstanding. The number of shares has increased by 1.72% in one year.
| Shares Outstanding | 294.05M |
| Shares Change (YoY) | +1.72% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 28.00% |
| Owned by Institutions (%) | 43.89% |
| Float | 188.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 27.47 |
| PS Ratio | 24.40 |
| Forward PS | 20.25 |
| PB Ratio | 0.77 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.76, with a Debt / Equity ratio of 0.06.
| Current Ratio | 7.76 |
| Quick Ratio | 7.22 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -12.60% and return on invested capital (ROIC) is -18.97%.
| Return on Equity (ROE) | -12.60% |
| Return on Assets (ROA) | -9.80% |
| Return on Capital (ROIC) | -18.97% |
| Revenue Per Employee | $61,072 |
| Profits Per Employee | -$250,679 |
| Employee Count | 586 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -21.73M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.64% in the last 52 weeks. The beta is 0.39, so ABCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -62.64% |
| 50-Day Moving Average | 3.38 |
| 200-Day Moving Average | 4.39 |
| Relative Strength Index (RSI) | 44.50 |
| Average Volume (20 Days) | 1,938,331 |
Short Selling Information
The latest short interest is 18.78 million, so 6.39% of the outstanding shares have been sold short.
| Short Interest | 18.78M |
| Short Previous Month | 19.72M |
| Short % of Shares Out | 6.39% |
| Short % of Float | 9.98% |
| Short Ratio (days to cover) | 9.56 |
Income Statement
In the last 12 months, ABCL had revenue of $35.79 million and -$146.90 million in losses. Loss per share was -$0.52.
| Revenue | 35.79M |
| Gross Profit | 35.79M |
| Operating Income | -227.23M |
| Pretax Income | -168.63M |
| Net Income | -146.90M |
| EBITDA | -138.09M |
| EBIT | -168.63M |
| Loss Per Share | -$0.52 |
Balance Sheet
The company has $723.02 million in cash and $68.08 million in debt, giving a net cash position of $654.94 million or $2.23 per share.
| Cash & Cash Equivalents | 723.02M |
| Total Debt | 68.08M |
| Net Cash | 654.94M |
| Net Cash Per Share | $2.23 |
| Equity (Book Value) | 1.13B |
| Book Value Per Share | 3.84 |
| Working Capital | 709.07M |
Cash Flow
In the last 12 months, operating cash flow was -$41.52 million and capital expenditures -$86.10 million, giving a free cash flow of -$127.63 million.
| Operating Cash Flow | -41.52M |
| Capital Expenditures | -86.10M |
| Free Cash Flow | -127.63M |
| FCF Per Share | -$0.44 |
Margins
Gross margin is 100.00%, with operating and profit margins of -634.92% and -410.47%.
| Gross Margin | 100.00% |
| Operating Margin | -634.92% |
| Pretax Margin | -471.19% |
| Profit Margin | -410.47% |
| EBITDA Margin | -385.85% |
| EBIT Margin | -471.19% |
| FCF Margin | -356.61% |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.72% |
| Shareholder Yield | -1.72% |
| Earnings Yield | -16.82% |
| FCF Yield | -14.61% |
Analyst Forecast
The average price target for ABCL is $16.50, which is 455.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.50 |
| Price Target Difference | 455.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 19.26% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABCL has an Altman Z-Score of 2.03 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.03 |
| Piotroski F-Score | 2 |